Avri Havron
Director/Board Member at COLLPLANT BIOTECHNOLOGIES LTD.
Net worth: - $ as of 2024-03-30
Profile
Dr. Abraham Havron is an Independent Director at CollPlant Biotechnologies Ltd.
and an Independent Director at Enlivex Therapeutics Ltd.
He is on the Board of Directors at CollPlant Ltd., CollPlant Biotechnologies Ltd.
and Enlivex Therapeutics Ltd.
Dr. Havron was previously employed as an Independent External Director by MediWound Ltd., an Independent Director by Kamada Ltd., a Chief Executive Officer & Director by OPKO Biologics Ltd., a Chief Executive Officer & Director by Prolor Biotech Ltd., a Chief Technology Officer & Vice President by Clal Biotechnology Industries Ltd., a Vice President-Manufacturing & Process Development by Biotechnology General (Israel) Ltd., and a Director-Research & Development by Interpharm Laboratories Ltd.
He also served on the board at Pam-Bio Ltd.
and Enlivex Therapeutics Ltd.
/Old/.
He received his undergraduate degree from The Hebrew University of Jerusalem and a doctorate degree from Weizmann Institute of Science.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-19 | 0 ( -.--% ) | - $ | 2024-03-30 |
Avri Havron active positions
| Companies | Position | Start |
|---|---|---|
| COLLPLANT BIOTECHNOLOGIES LTD. | Director/Board Member | 2016-04-30 |
| ENLIVEX THERAPEUTICS LTD. | Director/Board Member | 2013-12-31 |
CollPlant Ltd.
 CollPlant Ltd. BiotechnologyHealth Technology CollPlant Ltd. specializes in the development and commercialization of medical products. It develops and commercialize tissue repair products for orthobiologics and advanced wound care markets. The company was founded by Tsafrir Feigin Yehuda and Oded Shoseyov in 2004 and is headquartered in Ness Ziona, Israel. | Director/Board Member | 2016-04-30 |
Former positions of Avri Havron
| Companies | Position | End |
|---|---|---|
Pam-Bio Ltd.
 Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | Director/Board Member | 2018-12-31 |
| KAMADA LTD. | Director/Board Member | 2018-12-19 |
| MEDIWOUND LTD. | Director/Board Member | 2017-06-21 |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Chief Executive Officer | 2012-12-31 |
Prolor Biotech Ltd.
 Prolor Biotech Ltd. BiotechnologyHealth Technology Prolor Biotech Ltd. develops proprietary versions of already-approved therapeutic proteins. The private company is based in Nes Ziona, Israel. | Chief Executive Officer | 2012-12-31 |
Training of Avri Havron
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Weizmann Institute of Science | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Finance |
| KAMADA LTD. | Health Technology |
| MEDIWOUND LTD. | Health Technology |
| COLLPLANT BIOTECHNOLOGIES LTD. | Health Technology |
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| Private companies | 7 |
|---|---|
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Health Technology |
CollPlant Ltd.
CollPlant Ltd. BiotechnologyHealth Technology CollPlant Ltd. specializes in the development and commercialization of medical products. It develops and commercialize tissue repair products for orthobiologics and advanced wound care markets. The company was founded by Tsafrir Feigin Yehuda and Oded Shoseyov in 2004 and is headquartered in Ness Ziona, Israel. | Health Technology |
Interpharm Laboratories Ltd.
 Interpharm Laboratories Ltd. BiotechnologyHealth Technology Part of Merck KGaA, Interpharm Laboratories Ltd. is an Israeli company that develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases. The private company is based in Rehovot, Israel. The company was founded by Israel Makov. | Health Technology |
Biotechnology General (Israel) Ltd.
 Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Health Technology |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
Pam-Bio Ltd.
Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | Health Technology |
Prolor Biotech Ltd.
Prolor Biotech Ltd. BiotechnologyHealth Technology Prolor Biotech Ltd. develops proprietary versions of already-approved therapeutic proteins. The private company is based in Nes Ziona, Israel. | Health Technology |
- Stock Market
- Insiders
- Avri Havron